Community Bank’s Takeda Pharmaceutical TAK Stock Holding History

Community Bank’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-594	Closed	-$9.78K	–	461
2023 Q1	$9.78K	Hold	594	–	–	﹤0.01%	380
2022 Q4	$9.27K	Buy	594 +203	+52%	+$2.83K	﹤0.01%	385
2022 Q3	$5K	Buy	+391	New	+$5.44K	﹤0.01%	445
2019 Q2	–	Sell	-110	Closed	-$2K	–	480
2019 Q1	$2K	Buy	+110	New	+$2.21K	﹤0.01%	450

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Community Bank's TAK Position: Q2 2023 in Review

Community Bank sold out of Takeda Pharmaceutical (TAK) in Q2 2023, closing a stake of 594 shares — an estimated $9.78K sold.

Community Bank first reported a position in TAK in Q1 2019 and held it in 4 quarters. The position peaked at $9.78K in Q1 2023. 310 funds tracked by Wall St. Rank hold TAK as of Q2 2023.

Community Bank reported no remaining Takeda Pharmaceutical position as of Q2 2023 after selling out during the quarter.
Community Bank sold 594 Takeda Pharmaceutical shares in Q2 2023, an estimated $9.78K.
Community Bank first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 4 quarters.
Community Bank's Takeda Pharmaceutical position peaked at $9.78K in Q1 2023.
310 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2023.

Based on Community Bank's 13F filing for Q2 2023, filed 1 Aug 2023.